Companies / Health Care / Health Care Equipment
Edwards Lifesciences stock buybacks
EW$1.2Bbought back in the 12 months to Jun 30, 2026
Edwards Lifesciences bought back $1.2B of its stock in the last twelve months, $1.0B more than it paid out in stock compensation. Its share count is down 1.8% from a year earlier.
Show as table
| Period | Value |
|---|---|
| Q3 '20 | $1.4M |
| Q4 '20 | $200,000 |
| Q1 '21 | $302.6M |
| Q2 '21 | $111.9M |
| Q3 '21 | $1.8M |
| Q4 '21 | $96.5M |
| Q1 '22 | $405.6M |
| Q2 '22 | $355.1M |
| Q3 '22 | $100.4M |
| Q4 '22 | $866M |
| Q1 '23 | $249.3M |
| Q2 '23 | $7.5M |
| Q3 '23 | $174.4M |
| Q4 '23 | $448.4M |
| Q1 '24 | $200,000 |
| Q2 '24 | $158.1M |
| Q3 '24 | $901M |
| Q4 '24 | $100.1M |
| Q1 '25 | $258.6M |
| Q2 '25 | $5.5M |
| Q3 '25 | $588.7M |
| Q4 '25 | $40.6M |
| Q1 '26 | $421.8M |
| Q2 '26 | $153.3M |
Show as table
| Period | Value |
|---|---|
| Q3 '20 | 631.0M |
| Q4 '20 | 641.2M |
| Q1 '21 | 631.3M |
| Q2 '21 | 629.9M |
| Q3 '21 | 631.7M |
| Q4 '21 | 631.9M |
| Q1 '22 | 629.4M |
| Q2 '22 | 626.7M |
| Q3 '22 | 624.5M |
| Q4 '22 | 616.2M |
| Q1 '23 | 610.9M |
| Q2 '23 | 610.3M |
| Q3 '23 | 609.5M |
| Q4 '23 | 606.9M |
| Q1 '24 | 604.1M |
| Q2 '24 | 604.3M |
| Q3 '24 | 598.1M |
| Q4 '24 | 590.7M |
| Q1 '25 | 587.8M |
| Q2 '25 | 587.9M |
| Q3 '25 | 585.7M |
| Q4 '25 | 581.8M |
| Q1 '26 | 580.7M |
| Q2 '26 | 577.6M |
$153Mlast quarter (Q2 2026)
$1.0Bnet of stock compensation ($168M)
−1.8%diluted shares, 1 year
−7.3%diluted shares, 5 years
—dividends, 12 months
84%of free cash flow ($1.4B) spent on buybacks
$0raised by issuing stock, 12 months
576.4Mshares outstanding (Jul 31, 2026)
Share counts are adjusted for 2 stock splits (2-for-1, 3-for-1).
By fiscal year
Questions
- Does Edwards Lifesciences buy back its stock?
- Edwards Lifesciences bought back $1.2B of its stock in the last twelve months, $1.0B more than it paid out in stock compensation. Its share count is down 1.8% from a year earlier.
- How much did Edwards Lifesciences spend on buybacks in fiscal 2025?
- $893M, according to its 10-K for the fiscal year ending Dec 31, 2025.
- Is Edwards Lifesciences's share count going down?
- Its diluted share count changed −7.3% over five fiscal years and −1.8% over the last year.
Latest filing used: 10-Q for the period ending Jun 30, 2026, filed Aug 4, 2026 · open on SEC.gov